ASCO 2016: James Kochenderfer/NIH on Inducing Remissions in B-Cell Lymphoma: ascopost.com/videos/2016-as... Good summary of recent NIH CAR-T trial for DLBCL and fNHL. Long durations for those who achieve a CR.
ASCO 2016: NIH CAR-T Trial : ASCO 2016: James... - CLL Support
ASCO 2016: NIH CAR-T Trial
Written by
wmay13241
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Dr Sharman provides an update on an NIH CAR-T trial for relapsed/refractory DBLC
indolent lymphoma being run out of the NIH:...
Starting therapy 5 yrs post CAR-T with another immunotherapy trial, now epcoritamab
hospital
It was a nice long run and far exceeded the average duration of response to CAR-T in...
CAR-T coming to OSU Medical Center
Clinical Trial monitoring I got the first tangible hints that CAR-T (Chimeric Antigen Receptor – T...
The current status and challenges of CAR-T therapy in CLL
of interest.
\\"In recent years, novel immunotherapies, including CAR-T cell therapy, have...
CLL Society/ CAR-T! Read the story of Dr. Brian Koffman's 3 years of durable remission post-CAR-T!
CAR-T cells. Read about his three years of durable remission here....
hu CAR-T 19 IL-18 TRIAL 14 DAY BMB REPORT AND DR. VISIT DAY 21
CAR-T Therapy Inquiry
CAR-T treatment for CLL
CAR T for richter transformation
